Evaluating therapeutic efficacy of VASANTHAKUSUMAKARAM MATHIRAI for PITHA NEER CHURUKU(Urinary Tract Infection)

Evaluating therapeutic efficacy of Siddha formulation VASANTHA KUSUMAKARAM MATHIRAI in the management of PITHA NEER CHURUKU (Urinary tract infection)

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/03/050696

Enrollment

Registered

2023-03-14

Start date

Unknown

Completion date

Unknown

Last updated

2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N390- Urinary tract infection, site notspecified

Interventions

Intervention1: Vasanthakusumakaram Mathirai: 1 tablet oral route twice a day for 15 days Control Intervention1: NIL: NIL

Eligibility

Inclusion criteria

Inclusion criteria: Patients with or without the symptoms such as burning micturition, dysuria, supra pubic pain and scanty urination. Patients with Uncomplicated UTI . Patients who are willing to go for urine culture, urine routine and blood investigations Patients with urine culture significant for bacteria (e.g., Escherichia coli, Klebsiella, Enterococci, Staphylococcus etc...)

Exclusion criteria

Exclusion criteria: Vulnerable groups (Pregnancy and lactation) K/C/O Genitourinary tuberculosis K/C/O Diabetes Mellitus Malignancy K/C/O Sexually transmitted diseases like HIV, Syphilis Patient not willing to undergo urine routine and urine culture

Design outcomes

Primary

Measure	Time frame
It is assessed by negative urine culture for bacterial growthTimepoint: 12 Months	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactDr A Surya Dr D Anandhalakshmi Dr A Pavithra

National Institute of Siddha

dr.h.nalinisofia@gmail.com8939899363

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026